Minerva Neurosciences (NERV) Earnings Date & Reports

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NERV is expected to report earnings to rise 13.71% to -19 cents per share on August 04

Minerva Neurosciences NERV Stock Earnings Reports

Q2'26

Est.

$-0.19

Q1'26

Missed

by $0.04

Q4'25

Missed

by $0.53

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.47

The last earnings report on May 05 showed earnings per share of -17 cents, missing the estimate of -12 cents. With 52.39K shares outstanding, the current market capitalization sits at 217.57M.

View a ticker or compare two or three

Compare

NERV

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NERV